Skip to main content
SpringerLink
Log in

Combination Therapy for Ablation

  • Chapter
Tumor Ablation

  • 2699 Accesses

Abstract

Radiofrequency ablation (RFA) is most effective for small tumors. In metastases, complete treatment has been reported in 91% of tumors <2cm, 88% of tumors <3cm, and 53% of 3 to 4.5 cm tumors (1,2). In hepatocellular carcinoma (HCC), RFA achieved complete necrosis in 90% of lesions <3cm and 71% of lesions 3.1 to 5.0cm in diameter (3). In our practice, most patients present with larger lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001;221:159–166.

    Article  PubMed  CAS  Google Scholar 

  2. de Baere T, Elias D, Dromain C, et al. Radio-frequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR 2000;175:1619–1625.

    Article  PubMed  Google Scholar 

  3. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 2000;214:761–768.

    Article  PubMed  CAS  Google Scholar 

  4. Gillams AR, Lees WR. Radiofrequency ablation of colorectal metastases in 167 patients. Eur Radiol 2004;14(12):2261–2267.

    Article  PubMed  CAS  Google Scholar 

  5. Chopra S, Dodd GD III, Chintapalli KN, et al. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT. AJR 2001;177:381–387.

    Article  PubMed  CAS  Google Scholar 

  6. Izumi N, Asahina Y, Noguchi O, et al. Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation. Cancer 2001;91:949–956.

    Article  PubMed  CAS  Google Scholar 

  7. Gillams AR, Lees WR. Thermal ablation induced changes in hepatic arterial perfusion. Radiology 1999;213P;382.

    Google Scholar 

  8. Goldberg S, Hahn P, Halpern E, Fogle R, Gazelle GS. Radiofrequency tissue ablation: effect of pharmacological modulation of blood flow on coagulation diameter. Radiology 1998;209:761–767.

    Article  PubMed  CAS  Google Scholar 

  9. Germer CT, Isbert C, Albrecht D, et al. Laser-induced thermotherapy combined with hepatic arterial embolization in the treatment of liver tumors in a rat tumor model. Ann Surg 1999;230:55–62.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  10. Denys A, de Baere T, Mahe C, et al. Radiofrequency tissue ablation of the liver: effects of vascular occlusion on lesion diameter and biliary and portal damages in a pig model. Eur Radiol 2001;11:2102–2108.

    Article  PubMed  CAS  Google Scholar 

  11. Chinn SB, Lee FT, Kennedy GD, et al. Effect of vascular occlusion on radiofrequency ablation of the liver: results in a porcine model. AJR 2001;176;789–795.

    Article  PubMed  CAS  Google Scholar 

  12. Yamasaki T, Kurokawa F, Shirahashi H, et al. Percutaneous radiofrequency ablation therapy with combined angiography and CT assistance for patients with hepatocellular carcinoma. Cancer 2001;91:1342–1348.

    Article  PubMed  CAS  Google Scholar 

  13. Lees WR, Schumillian C, Gillams AR. Hypotensive anesthesia improves the effectiveness of radiofrequency ablation in the liver. Radiology 2000;217:228.

    Article  Google Scholar 

  14. Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations and complications. Ann Surg Oncol 2000;7:593–600.

    Article  PubMed  CAS  Google Scholar 

  15. Gruenberger T, Jourdan JL, Zhao J, King J, Morris DL. Reduction in recurrence risk for involved or inadequate margins with edge cryotherapy after liver resection for colorectal metastases. Arch Surg 2001;136:1154–1157.

    Article  PubMed  CAS  Google Scholar 

  16. Weber JC, Navarra G, Jiao LR, Nicholls JP, Jensen SL, Habib I. New technique for liver resection using heat coagulation necrosis. Ann Surg 2002;236(5):560–563.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Montorsi M, Santambrogio R, Bianchi P, et al. Radiofrequency interstitial thermal ablation of hepatocellular carcinoma in liver cirrhosis: role of the laparoscopic approach. Surg Endosc 2001;15:141–145.

    Article  PubMed  CAS  Google Scholar 

  18. Scott DJ, Fleming JB, Watumull LM, et al. Accuracy and effectiveness of laparoscopic vs. open hepatic RF ablation. Surg Endosc 2001;15:135–140.

    Article  PubMed  CAS  Google Scholar 

  19. Miao Y, Ni Y, Yu J, Marchal G. A comparative study on validation of a novel cooled-wet electrode for radiofrequency liver ablation. Invest Radiol 2000;35:438–444.

    Article  PubMed  CAS  Google Scholar 

  20. Goldberg SN, Ahmed M, Gazelle GS, et al. Radio-frequency thermal ablation with NaCl solution injection: effect of electrical conductivity on tissue heating and coagulation-phantom and porcine liver study. Radiology 2001;219:157–165.

    Article  PubMed  CAS  Google Scholar 

  21. Livraghi T, Goldberg N, Monti F, et al. Saline enhanced radiofrequency tissue ablation in the treatment of liver metastases. Radiology 1997;202:205–210.

    Article  PubMed  CAS  Google Scholar 

  22. Douillard JY, V303 Study Group. Irinotecan and high dose fluorouracil/leucovorin for metastatic colorectal cancer. Oncology 2000;14:51–55.

    PubMed  CAS  Google Scholar 

  23. Giacchetti S, Perpoint B, Zidani R, et al. Phase III multicenter trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first line treatment of metastatic colorectal cancer. J Clin Oncol 2000;18:136–147

    PubMed  CAS  Google Scholar 

  24. Bismuth H, Adam R, Levi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509–522.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  25. Shankar A, Leonard P, Renaut AJ, et al. Neoadjuvant therapy improves resectability rates for colorectal cancer. Ann R Coll Surg Engl 2001;83:85–88.

    PubMed  CAS  PubMed Central  Google Scholar 

  26. Gillams A, Lees W. Should thermal ablation be offered to patients with colorectal liver metastases downstaged by chemotherapy? Radiology 2000;217(P):539.

    Google Scholar 

  27. Preketes A, Caplehorn J, King J, et al. Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy. World J Surg 1995;19:768–771.

    Article  PubMed  CAS  Google Scholar 

  28. Kainuma O, Asano T, Aoyama H, et al. Combined therapy with radiofrequency thermal ablation and intra-arterial infusion chemotherapy for hepatic metastases from colorectal cancer. Hepatogastroenterology 1999;46:1071–1077.

    PubMed  CAS  Google Scholar 

  29. Tellez C, Benson A, Lyster M, et al. Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 1998;82:1250–1259.

    Article  PubMed  CAS  Google Scholar 

  30. Livraghi T, Goldberg N, Solbiati L, et al. Percutaneous radiofrequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology 2001;220:145–149.

    Article  PubMed  CAS  Google Scholar 

  31. Chung MH, Pisegna J, Spirt M, et al. Hepatic cytoreduction followed by a novel long-acting somatostatin analogue: a paradigm for intractable neuroendocrine tumors metastatic to the liver. Surgery 2001;130:954–964.

    Article  PubMed  CAS  Google Scholar 

  32. Goldberg SN, Saldinger P, Gazelle GS, et al. Percutaneous tumor ablation: increased necrosis with combined radiofrequency ablation and intratumoral doxorubicin in a rat breast tumor model. Radiology 2001;220:420–427.

    Article  PubMed  CAS  Google Scholar 

  33. Higuchi T, Kikuchi M, Okazaki M. Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathological study of 84 resected cases. Cancer 1994;72:2259–2267.

    Article  Google Scholar 

  34. Koda M, Murawaki Y, Mitsuda A, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma. Cancer 2001;92:1516–1524.

    Article  PubMed  CAS  Google Scholar 

  35. Pacella CM, Bizzarri G, Cecconi O, et al. Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. Radiology 2001;219:669–678.

    Article  PubMed  CAS  Google Scholar 

  36. Lencioni R, Cioni D, Donati F, Bartolozzi C. Combination of interventional therapies in hepatocellular carcinoma. Hepatogastroenterology 2001;48:8–14.

    PubMed  CAS  Google Scholar 

  37. Ikeda K, Arase Y, Saitoh S, et al. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor. Hepatology 2000;32:228–232.

    Article  PubMed  CAS  Google Scholar 

  38. Okuno M, Kojima S, Moriwaki H. Chemoprevention of hepatocellular carcinoma: concept progress and perspectives. J Gastroenterol Hepatol 2001;16:1329–1355.

    Article  PubMed  CAS  Google Scholar 

  39. Muto Y, Moriwaki H, Ninomiya M, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid in patients with HCC. N Engl J Med 1996;334:1561–1567.

    Article  PubMed  CAS  Google Scholar 

  40. Lau WY, Leung TWT, Ho S, et al. Adjuvant intra-arterial iodine-131 labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial. Lancet 1999;353:797–801.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Honorary Consultant, Imaging, Middlesex Hospital, University College of London Medical School, London, UK

    Allison Gillams MD (Senior Lecturer)

  2. Department of Medical Imaging, Middlesex Hospital, University College of London Medical School, London, UK

    William R. Lees MD (Professor of Medical Imaging)

Authors
  1. Allison Gillams MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William R. Lees MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA

    Eric vanSonnenberg MD (Chief of Radiology, Interventional Radiologist) (Chief of Radiology, Interventional Radiologist)

  2. Brigham and Women’s Hospital Children’s Hospital, Boston, MA, 02115, USA

    Eric vanSonnenberg MD (Chief of Radiology, Interventional Radiologist) (Chief of Radiology, Interventional Radiologist)

  3. Boston, MA, 02115, USA

    William N. McMullen (Interventional Oncology Consultant) (Interventional Oncology Consultant)

  4. Department of Radiology, Ospedale Civile Busto Arsizio, 21052, Busto Arsizio, Italy

    Luigi Solbiati MD (Chairman) (Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Gillams, A., Lees, W.R. (2005). Combination Therapy for Ablation. In: vanSonnenberg, E., McMullen, W.N., Solbiati, L., Livraghi, T., Müeller, P.R., Silverman, S.G. (eds) Tumor Ablation. Springer, New York, NY. https://doi.org/10.1007/0-387-28674-8_24

Download citation

  • DOI: https://doi.org/10.1007/0-387-28674-8_24

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95539-1

  • Online ISBN: 978-0-387-28674-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation